ABSTRACT
OBJECTIVE Oral anticoagulant (OAC) use raises the risk of death in life-threatening conditions such as hemorrhagic stroke, trauma and traumatic brain injury. We sought to describe the national characteristics of Emergency Medical Services patients with a history of OAC use.
METHODS We used prehospital electronic medical record data from 2018-2020 from the ESO Data Collaborative. We included adults (age≥18 years) receiving 911 EMS care. OAC use included warfarin, dabigatran, rivaroxaban and apixaban. We determined the incidence of EMS calls by OAC users as well as their variation by EMS agency. We compared EMS call, patient, and response characteristics between OAC and non-OAC users, including primary impressions and hospital diagnoses.
RESULTS There were 16,244,550 adult 911 EMS events, including 906,575 by OAC users (56 per 1,000 911 events). Compared with non-OAC users, OAC users were more likely to be older (73.6 vs. 56.9 years), white (78.0% vs. 51.4%) and non-Hispanic (84.5% vs. 78.0%). Incidents involving OAC users were more likely at nursing homes, rehabilitation or long-term care facilities (17.0% vs. 9.2%) but less likely to involve trauma (14.7% vs. 18.1%) or cardiac arrest (1.2% vs. 1.4%). Among OAC users, the most common EMS primary clinical impressions were chest pain (7.4%), altered mental status (7.3%), injury (6.5%), abdominal pain (4.3%), and brain injury (2.8%).
CONCLUSIONS In this national series of prehospital events, 1 in 18 adult EMS encounters involved OAC users. These results provide key perspectives on the presentation of the OAC users in EMS care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the Ohio State University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Contact: Henry E. Wang, MD, MS, Professor and Vice Chair for Research, Department of Emergency Medicine, The Ohio State University, 376 W. 10th Ave, 789 Prior Hall, Columbus, OH 43210, Henry.wang{at}osumc.edu, 205-410-1267
Presented at: National Association of EMS Physicians Annual Meeting, Tampa, Florida, January 2023.
Data Availability
Data are not available from the authors.
